North China Pharmaceutical Group Gets Europe GMP Nod For Injectable
This article was originally published in PharmAsia News
Executive Summary
Huamin Co., a subsidiary of North China Pharmaceutical Group (NCPG), officially received a GMP certificate from the Medicines and Healthcare products Regulators Agency in the U.K., indicating its sterile powder for injection can be sold in the EU region.